Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance.

TitleAdipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance.
Publication TypeJournal Article
Year of Publication2016
AuthorsO'Sullivan TE, Rapp M, Fan X, Weizman O-E, Bhardwaj P, Adams NM, Walzer T, Dannenberg AJ, Sun JC
JournalImmunity
Volume45
Issue2
Pagination428-41
Date Published2016 08 16
ISSN1097-4180
KeywordsAdipose Tissue, Animals, Basic-Leucine Zipper Transcription Factors, Cell Differentiation, Cells, Cultured, Cytokines, Humans, Immunity, Innate, Inflammation Mediators, Insulin Resistance, Interferon-gamma, Interleukin-12, Lymphocytes, Macrophages, Mice, Mice, Inbred C57BL, Mice, Transgenic, Obesity, STAT4 Transcription Factor, T-Box Domain Proteins
Abstract

Innate lymphoid cells (ILCs) function to protect epithelial barriers against pathogens and maintain tissue homeostasis in both barrier and non-barrier tissues. Here, utilizing Eomes reporter mice, we identify a subset of adipose group 1 ILC (ILC1) and demonstrate a role for these cells in metabolic disease. Adipose ILC1s were dependent on the transcription factors Nfil3 and T-bet but phenotypically and functionally distinct from adipose mature natural killer (NK) and immature NK cells. Analysis of parabiotic mice revealed that adipose ILC1s maintained long-term tissue residency. Diet-induced obesity drove early production of interleukin (IL)-12 in adipose tissue depots and led to the selective proliferation and accumulation of adipose-resident ILC1s in a manner dependent on the IL-12 receptor and STAT4. ILC1-derived interferon-γ was necessary and sufficient to drive proinflammatory macrophage polarization to promote obesity-associated insulin resistance. Thus, adipose-resident ILC1s contribute to obesity-related pathology in response to dysregulated local proinflammatory cytokine production.

DOI10.1016/j.immuni.2016.06.016
Alternate JournalImmunity
PubMed ID27496734
PubMed Central IDPMC5004886
Grant ListR01 AI100874 / AI / NIAID NIH HHS / United States
P30 CA008748 / CA / NCI NIH HHS / United States
F30 AI122721 / AI / NIAID NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
R01 CA154481 / CA / NCI NIH HHS / United States

Person Type: